All In Biotech

Drug Trial Radar · NCT05710848

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer

Last checked: Nov 19, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Jul 11, 2023

Primary completion

May 2026

Study completion Aug 2026

Sponsor

Lead sponsor
SURGE TherapeuticsIndustry
Sponsor type
Industry
First posted
Feb 2, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.

Conditions

  • Non-muscle-invasive Bladder Cancer

Interventions

  • STM-416Drug

    STM-416 monotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of dose-limiting toxicities (DLTs) [Safety and Tolerability] Phase 1Time frame: 21 days
  2. Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] Phase 1Time frame: Time on trial up to 90 days
  3. Recurrence free survival time (Phase 2a)Time frame: Through study completion up to 24 months

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • East Valley Urology Center of Arizona

    Mesa, Arizona · Recruiting

  • Arizona Urology Specialists

    Tucson, Arizona · Completed

  • Arkansas Urology

    Little Rock, Arkansas · Recruiting

  • Unio Specialty Care - A Genesis Healthcare Partners Facility

    Bakersfield, California · Recruiting

  • Genesis Research

    Downey, California · Recruiting

  • Urology Center of Southern California

    Murrieta, California · Recruiting

  • Advanced Urology Institute

    Daytona Beach, Florida · Recruiting

  • University of Florida

    Gainesville, Florida · Recruiting

  • Advent Health

    Orlando, Florida · Recruiting

  • Anna Arundel Urology

    Annapolis, Maryland · Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • Michigan Institute of Urology

    Troy, Michigan · Recruiting

  • The Ohio State University

    Columbus, Ohio · Recruiting

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina · Recruiting

  • Lowcountry Urology

    North Charleston, South Carolina · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Urology Partners of North Texas

    Fort Worth, Texas · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Recruiting

  • Houston Methodist

    Houston, Texas · Recruiting

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.